[First Test Tube News Report] Guan Nian joined hands with Hong Kong's First Test Tube to draw a new blueprint for assisted reproduction

On February 6, 2025,"Guannian", a high-end brand owned by Beijing Changsheng Quangshi Technology Co., Ltd., and the First IVF Center (Hong Kong) Co., Ltd.(hereinafter referred to as the "First IVF"), a subsidiary of the U.S. listed company NEWGENIVF Group Limited, officially announced the conclusion of in-depth strategic cooperation. This strong alliance is like dropping a blockbuster in the field of assisted reproduction, which will surely set off new waves in the development of the industry and jointly open a new chapter in assisted reproduction.

Guannian, as a cutting-edge and pioneering brand in the field of anti-aging technology in China, has shouldered the mission of exploring the secrets of life and promoting the deep integration of technology and health since its birth. Relying on its profound scientific research heritage, it is like a skilled craftsman, focusing on cleverly integrating the world's top life science technology with the physical characteristics of Oriental people. Focusing accurately on the new year and creating personalized technological anti-aging and life extension solutions tailored to the health needs of China people, it is unique in the industry and has attracted much attention.

Dr. Lin Xiongbin, the company's chief scientist, is also a leader on the road to scientific research. He devoted himself to research and created autologous stem cell technology with his persistence and love for science. This technology is like a bright star in the industry, especially in the field of male and female autologous reproductive stem cells. For those who suffer from infertility, premature ovarian failure and decline in the reproductive function of men and women, this technology is like a ray of hope, illuminating their path towards their childbearing dreams and showing huge application potential.

As an important member of NEWGENIVF Group Limited (stock code: NIVF), a U.S. listed company, since its establishment in Hong Kong in 2010, Test Tube No. 1 has emerged in the field of fertility assistance as Asia's leading all-round life technology medical group. It is a well-recognized professional institution for fertility assistance. With its outstanding professional strength, it is like a caring guardian and has long provided high-quality fertility assistance services to customers in the mainland of China, Hong Kong, Macao and Taiwan regions, Southeast Asia and other places.

The international layout of Test Tube 1 is extensive and in-depth, with clinics located in Thailand, Cambodia and Kyrgyzstan, providing a full range of services to patients in appropriate jurisdictions. At the same time, service sites have been carefully set up in the United States, Japan, China Hong Kong, Singapore and other places, forming a wide-ranging, efficient and considerate service network, providing Asia-Pacific customers with a convenient and high-quality medical experience. It is worth mentioning that in April 2024, the group successfully landed on NASDAQ in the United States. This feat further demonstrated its strong strength and broad development prospects. It is like an eagle flying high in assisted reproduction Soars in the sky.

The cooperation between observing the New Year and the first test tube is a perfect integration of technology and resources. The two sides will comprehensively integrate their respective technical expertise and market resource advantages to deeply explore new opportunities hidden in the field of assisted reproduction. Guannian's advanced autologous stem cell technology will serve as a link that seamlessly connects the first test tube's world-class technical system with the huge global service network. Jointly create cutting-edge and reliable fertility assistance solutions for China's high-end customer base, helping them realize their dreams and have children, and bringing hope for new life to countless families.

"We are deeply honored to embark on this extraordinary journey of cooperation with First Test Tube Group. As a well-known assisted fertility service provider listed in the United States and in Asia, First Test Tube has a strong preference for the Guannian brand, which gives us more motivation to move forward." Mr. Wei Zhigang, founder of Guannian, said passionately,"Through this in-depth cooperation, the cutting-edge technology and excellent services carried by the Guannian brand will accurately reach more China families in need of help, and also explore the iterative development of fertility technology."

Ms. Luo Hong, CEO of First Test Tube Group in China, is also full of enthusiasm for cooperation. She said firmly: "Guannian's autologous stem cell technology achievements are obvious to all. We firmly believe that close cooperation between the two sides will surely inject new energy into the assisted pregnancy market and help more Chinese families embrace the advent of new life."

The cooperation between Concept and First Test Tube Group is also the first step for Guannian brand to go abroad. It is reported that Guannian will actively explore overseas markets in Southeast Asia. Like a brave explorer, he will embark on a new journey and bring advanced technology and high-quality services to more countries and regions.

About Beijing Changsheng Quangshi Technology Co., Ltd.

Beijing Changsheng Kuangshi Technology Co., Ltd. is an innovative pioneer in the field of anti-aging technology. It uses its cutting-edge brand "Guannian" to provide customized aging intervention and longevity health management services for customers. The company always adheres to the concept of innovation, professionalism and caring, constantly explores the boundaries of life sciences, and contributes its own strength to human health and longevity.

About Hong Kong First Test Tube Group

Hong Kong First Test Tube Group is Asia's leading all-round life technology medical group. Since its development in 2010, it has focused on providing a series of professional and comprehensive reproductive assistance services, covering cutting-edge technologies such as in vitro fertilization (IVF) treatment. With global high-quality medical resources as the cornerstone, the Group is like a solid dream builder, helping diverse families realize their childbearing dreams and bringing countless families the laughter of new life.